COURTNEY AUSTIN: Open Payments
NPI 1588334890 · ROCKLEDGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 42 payments from 17 companies in 2025. Trend: 2023 $615 · 2024 $1,124 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $206 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Organon LLC | 2 | $114 |
| Novartis Pharmaceuticals Corporation | 7 | $109 |
| Galderma Laboratories, L.P. | 4 | $66 |
| UCB, Inc. | 3 | $62 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| Botanix SB Inc | 2 | $33 |
| LEO Pharma Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
Products named: SKYRIZI, DUPIXENT, VTAMA, Bimzelx, NEMLUVIO, ILUMYA, SOFDRA, RINVOQ.
Industry payments across FL — which companies pay providers there.
